Edition:
India

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

3.57USD
1:26am IST
Change (% chg)

$0.28 (+8.51%)
Prev Close
$3.29
Open
$3.20
Day's High
$3.59
Day's Low
$3.20
Volume
212,523
Avg. Vol
413,889
52-wk High
$10.65
52-wk Low
$2.15

Latest Key Developments (Source: Significant Developments)

Sorrento Acquires Sofusa Lymphatic Delivery Technology Platform
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Sorrento Therapeutics Inc ::SORRENTO ACQUIRES THE SOFUSA™ LYMPHATIC DELIVERY PLATFORM FOR IMMUNE-ONCOLOGY (I-O) ANTIBODY THERAPEUTICS.SORRENTO THERAPEUTICS INC - ACQUIRED SOFUSA LYMPHATIC DELIVERY TECHNOLOGY PLATFORM FROM KIMBERLY-CLARK CORPORATION.  Full Article

Sorrento Therapeutics Enteres Into Securities Purchase Agreement
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Sorrento Therapeutics Inc ::SORRENTO THERAPEUTICS SAYS ON DEC 11, CO ENTERED INTO SECURITIES PURCHASE AGREEMENT - SEC FILING.SORRENTO THERAPEUTICS SAYS AGREED TO ISSUE, SELL TO PURCHASERS, IN A PRIVATE PLACEMENT, CONVERTIBLE PROMISSORY NOTES IN OF $50 MILLION.  Full Article

Sorrento Therapeutics says co entered into an at market issuance sales agreement with B. Riley FBR as sales agent
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Sorrento Therapeutics Inc :Sorrento Therapeutics - ‍On Nov. 9, 2017, co entered into an at market issuance sales agreement with B. Riley FBR, Inc., as sales agent - SEC Filing​.Sorrento Therapeutics Inc - ‍ Pursuant to sales agreement, co may offer and sell through agent up to $100 million in shares of common stock​.  Full Article

Sorrento Therapeutics files for mixed shelf of upto $350 mln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Sorrento Therapeutics Inc :Sorrento Therapeutics Inc files for mixed shelf of upto $350 million - SEC filing‍​.  Full Article